Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1974 2
1977 1
1984 1
1986 2
1988 1
1989 1
1990 1
1991 1
1992 1
1998 2
2000 1
2001 7
2002 12
2003 11
2004 16
2005 12
2006 10
2007 26
2008 29
2009 16
2010 9
2011 22
2012 37
2013 20
2014 25
2015 27
2016 22
2017 30
2018 37
2019 41
2020 51
2021 61
2022 39
2023 44
2024 47
2025 58
2026 26

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

633 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean kiyooka s[au] (6 results)?
Immune evasion through mitochondrial transfer in the tumour microenvironment.
Ikeda H, Kawase K, Nishi T, Watanabe T, Takenaga K, Inozume T, Ishino T, Aki S, Lin J, Kawashima S, Nagasaki J, Ueda Y, Suzuki S, Makinoshima H, Itami M, Nakamura Y, Tatsumi Y, Suenaga Y, Morinaga T, Honobe-Tabuchi A, Ohnuma T, Kawamura T, Umeda Y, Nakamura Y, Kiniwa Y, Ichihara E, Hayashi H, Ikeda JI, Hanazawa T, Toyooka S, Mano H, Suzuki T, Osawa T, Kawazu M, Togashi Y. Ikeda H, et al. Among authors: toyooka s. Nature. 2025 Feb;638(8049):225-236. doi: 10.1038/s41586-024-08439-0. Epub 2025 Jan 22. Nature. 2025. PMID: 39843734 Free PMC article.
Randomized Phase III Study of Pemetrexed Plus Cisplatin Versus Vinorelbine Plus Cisplatin for Completely Resected Stage II to IIIA Nonsquamous Non-Small-Cell Lung Cancer.
Kenmotsu H, Yamamoto N, Yamanaka T, Yoshiya K, Takahashi T, Ueno T, Goto K, Daga H, Ikeda N, Sugio K, Seto T, Toyooka S, Date H, Mitsudomi T, Okamoto I, Yokoi K, Saka H, Okamoto H, Takiguchi Y, Tsuboi M. Kenmotsu H, et al. Among authors: toyooka s. J Clin Oncol. 2020 Jul 1;38(19):2187-2196. doi: 10.1200/JCO.19.02674. Epub 2020 May 14. J Clin Oncol. 2020. PMID: 32407216 Clinical Trial.
Author Correction: Immune evasion through mitochondrial transfer in the tumour microenvironment.
Ikeda H, Kawase K, Nishi T, Watanabe T, Takenaga K, Inozume T, Ishino T, Aki S, Lin J, Kawashima S, Nagasaki J, Ueda Y, Suzuki S, Makinoshima H, Itami M, Nakamura Y, Tatsumi Y, Suenaga Y, Morinaga T, Honobe-Tabuchi A, Ohnuma T, Kawamura T, Umeda Y, Nakamura Y, Kiniwa Y, Ichihara E, Hayashi H, Ikeda JI, Hanazawa T, Toyooka S, Mano H, Suzuki T, Osawa T, Kawazu M, Togashi Y. Ikeda H, et al. Among authors: toyooka s. Nature. 2025 Aug;644(8076):E33. doi: 10.1038/s41586-025-09408-x. Nature. 2025. PMID: 40715527 Free PMC article. No abstract available.
Close Spatial Interactions between Cancer Cells and Cancer-Associated Fibroblasts Suppress Antitumor Immunity.
Naoi Y, Inukai Y, Izumikawa T, Nagasaki J, Ishino T, Ueda Y, Thu YM, Fujiwara M, Baba T, Makimoto G, Suzawa K, Okada K, Yamamoto KI, Sakaguchi M, Tomida S, Maeda Y, Toyooka S, Ando M, Togashi Y. Naoi Y, et al. Among authors: toyooka s. Cancer Immunol Res. 2025 Sep 2;13(9):1471-1484. doi: 10.1158/2326-6066.CIR-24-1144. Cancer Immunol Res. 2025. PMID: 40590673
Publisher Correction: Immune evasion through mitochondrial transfer in the tumour microenvironment.
Ikeda H, Kawase K, Nishi T, Watanabe T, Takenaga K, Inozume T, Ishino T, Aki S, Lin J, Kawashima S, Nagasaki J, Ueda Y, Suzuki S, Makinoshima H, Itami M, Nakamura Y, Tatsumi Y, Suenaga Y, Morinaga T, Honobe-Tabuchi A, Ohnuma T, Kawamura T, Umeda Y, Nakamura Y, Kiniwa Y, Ichihara E, Hayashi H, Ikeda JI, Hanazawa T, Toyooka S, Mano H, Suzuki T, Osawa T, Kawazu M, Togashi Y. Ikeda H, et al. Among authors: toyooka s. Nature. 2025 Mar;639(8053):E5. doi: 10.1038/s41586-025-08764-y. Nature. 2025. PMID: 39948434 Free PMC article. No abstract available.
Neoadjuvant Concurrent Chemo-Immuno-Radiation Therapy Followed by Surgery and Adjuvant Immunotherapy for Resectable Stage III N2 NSCLC: Primary Results From the SQUAT Trial (WJOG 12119L).
Hamada A, Soh J, Hata A, Nakamatsu K, Shimokawa M, Yatabe Y, Suzuki J, Tsuboi M, Horinouchi H, Sakairi Y, Tanahashi M, Toyooka S, Okada M, Matsuura N, Shigematsu H, Nishimura Y, Yamamoto N, Nakagawa K, Mitsudomi T. Hamada A, et al. Among authors: toyooka s. J Thorac Oncol. 2025 Aug;20(8):1098-1107. doi: 10.1016/j.jtho.2025.03.051. Epub 2025 Apr 9. J Thorac Oncol. 2025. PMID: 40216327 Clinical Trial.
Somatic mutations in tumor-infiltrating lymphocytes impact on antitumor immunity.
Mukohara F, Iwata K, Ishino T, Inozume T, Nagasaki J, Ueda Y, Suzawa K, Ueno T, Ikeda H, Kawase K, Saeki Y, Kawashima S, Yamashita K, Kawahara Y, Nakamura Y, Honobe-Tabuchi A, Watanabe H, Dansako H, Kawamura T, Suzuki Y, Honda H, Mano H, Toyooka S, Kawazu M, Togashi Y. Mukohara F, et al. Among authors: toyooka s. Proc Natl Acad Sci U S A. 2024 Aug 27;121(35):e2320189121. doi: 10.1073/pnas.2320189121. Epub 2024 Aug 21. Proc Natl Acad Sci U S A. 2024. PMID: 39167601 Free PMC article.
Single-cell and spatial transcriptomic characterization of pulmonary pleomorphic carcinoma.
Matsuoka A, Shien K, Tomida S, Ohki M, Hisamatsu K, Fujiwara R, Ishimura K, Fujii R, Higashihara T, Hayashi N, Okada K, Yoshichika R, Mukohara F, Yoshikawa M, Fukumoto Y, Suzawa K, Tomioka Y, Tanaka S, Miyoshi K, Okazaki M, Sugimoto S, Otani Y, Tanaka A, Inoue H, Togashi Y, Yamamoto H, Ennishi D, Toyooka S. Matsuoka A, et al. Among authors: toyooka s. Commun Biol. 2025 Dec 16;8(1):1773. doi: 10.1038/s42003-025-09162-w. Commun Biol. 2025. PMID: 41402584 Free PMC article.
An S100A8/A9 Neutralizing Antibody Potently Ameliorates Contact Hypersensitivity and Atopic Dermatitis Symptoms.
Gohara Y, Kinoshita R, Tomonobu N, Jiang F, Matsunaga Y, Hashimoto Y, Honjo T, Yamamoto KI, Murata H, Ochi T, Komalasari NLGY, Yamauchi A, Kuribayashi F, Sakaguchi Y, Futami J, Inoue Y, Kondo E, Toyooka S, Morizane S, Ishiko A, Morita S, Sagayama K, Nakao K, Sakaguchi M. Gohara Y, et al. Among authors: toyooka s. J Invest Dermatol. 2025 Aug;145(8):1930-1945.e3. doi: 10.1016/j.jid.2025.01.007. Epub 2025 Jan 21. J Invest Dermatol. 2025. PMID: 39848567 Free article.
633 results